CLINICAL_TRIALS
trial_result
· 2012-11-05
Clinical Trial Update: Optimizing Cimzia in Crohn's Patients [Phase 4]
Summary
Phase 4 clinical trial update evaluating certolizumab pegol (Cimzia) to optimize treatment in Crohn's disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Atlanta Gastroenterology Associates | Conditions: Crohn's Disease | Phase 4 | Status: UNKNOWN